Research summary, original research, 2023

Efficacy and User Experience of a Novel X-Ray Shield on Operator Radiation Exposure During Cardiac Catheterization: A Randomized Controlled Trial

Davidsen C, Ytre-Hauge K, Samnøy AT, Vikenes K, Lancellotti P, Tuseth V. Circulation. Cardiovascular interventions. 2023

Read the original paper

In plain language

In a Norwegian randomized trial of 103 coronary procedures, adding a flexible on-patient lead shield to standard shields lowered measured operator dose at the thyroid collar by about 84%, without raising patient dose. Operators rated it easy to use.

At a glance

Type of study
Original research, Randomized trial
Who was studied
Interventional cardiologists
Size
n = 103 procedures
Where
Norway
Summary based on
the full text

What it found

  • Adding the flexible multiconfiguration shield to routine table- and ceiling-mounted shielding cut median relative operator dose by 84.4%.

    Key figures: 3.63 (IQR 2.62-6.37) vs 0.57 (IQR 0.27-1.06) μSv/µGy·m2×10-3; 84.4% reduction, P<0.001

  • Median absolute operator dose per procedure fell by 79.6%.

    Key figures: 7.14 vs 1.46 μSv; P<0.001

  • Extrapolated to 500 procedures a year, estimated annual operator dose fell from 3.6 to 0.7 mSv.

    Key figures: 3.6 to 0.7 mSv/year

  • Reduction was similar in diagnostic angiography and intracoronary procedures, and the shield was the only significant predictor of lower dose in regression.

    Key figures: 81.6% (intracoronary) and 86.4% (CA) reduction; P<0.001

  • User feedback was almost entirely positive and patient radiation exposure did not differ between groups.

    Key figures: 99% positive feedback

Limits to keep in mind

Single-center pilot trial of 103 procedures with 10 operators over two weeks, dose measured only at the thyroid collar of the primary operator, and user feedback from a small group; two authors are co-inventors with a pending patent.

How this summary was made

ORSIF prepared this summary with AI assistance from the full text of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.